# U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
## Analytical Brief - The Continuum Report

---

## AGENCY CLASSIFICATION

| Attribute | Value |
|-----------|-------|
| **Official Name** | United States Department of Health and Human Services |
| **Common Abbreviation** | HHS |
| **Established** | April 11, 1953 (as HEW); October 17, 1979 (current name) |
| **Type** | Cabinet-level Executive Department |
| **Current Head** | Secretary Robert F. Kennedy Jr. (26th Secretary, confirmed February 13, 2025) |
| **Headquarters** | Hubert H. Humphrey Building, Washington, D.C. |
| **Employees** | ~80,000 |
| **Annual Budget** | $1.802 trillion (FY2025 estimated outlays) |
| **Jurisdiction** | Healthcare, public health, human services, medical research |

---

## MISSION STATEMENT

"To enhance the health and well-being of all Americans by providing effective health and human services and by fostering sound, sustained advances in the sciences underlying medicine, public health, and social services."

---

## HISTORICAL OVERVIEW

### Formation and Evolution
Created as the Department of Health, Education, and Welfare (HEW) on April 11, 1953 under President Eisenhower, consolidating health and welfare functions. Renamed Health and Human Services on October 17, 1979 when Education became a separate department under President Carter.

### Key Historical Developments
- **1953**: HEW established; inherited Public Health Service (founded 1798), Social Security Administration, FDA
- **1965**: Medicare and Medicaid created under Lyndon Johnson
- **1970**: Environmental functions transferred to new EPA
- **1979**: Education functions transferred to new Department of Education; renamed HHS
- **1994**: Social Security Administration became independent agency
- **2010**: Affordable Care Act dramatically expanded HHS role
- **2020-2023**: COVID-19 pandemic response defined HHS operations

### The Largest Civilian Department
HHS controls approximately 28% of all federal outlays—more than any other civilian agency. This reflects the massive entitlement programs (Medicare, Medicaid) that dominate modern federal spending.

---

## ORGANIZATIONAL STRUCTURE

### Major Operating Divisions (11 total)

| Division | Key Functions |
|----------|---------------|
| **Centers for Medicare & Medicaid Services (CMS)** | Medicare, Medicaid, CHIP, ACA marketplace |
| **Centers for Disease Control and Prevention (CDC)** | Disease surveillance, immunization, public health |
| **Food and Drug Administration (FDA)** | Drug approval, food safety, medical devices |
| **National Institutes of Health (NIH)** | Biomedical research (largest funder globally) |
| **Health Resources and Services Administration (HRSA)** | Health workforce, underserved populations |
| **Indian Health Service (IHS)** | Healthcare for American Indians/Alaska Natives |
| **Substance Abuse and Mental Health Services (SAMHSA)** | Addiction and mental health services |
| **Administration for Children and Families (ACF)** | Child welfare, TANF, Head Start |
| **Administration for Community Living (ACL)** | Elderly and disability services (planned dissolution) |
| **Agency for Healthcare Research and Quality (AHRQ)** | Healthcare quality research |
| **Agency for Toxic Substances and Disease Registry (ATSDR)** | Environmental health |

### 2025 Reorganization (RFK Jr.)
Major structural changes underway:
- Reduction from 28 to 15 top-level divisions
- New "Administration for a Healthy America" (merging 5 agencies)
- CDC reoriented toward infectious disease focus
- 20% workforce reduction target (~20,000 positions)

---

## BUDGET & FUNDING

### FY2025 Budget Analysis

| Category | Amount | % of Total |
|----------|--------|------------|
| **Total Estimated Outlays** | $1.802 trillion | 100% |
| **Medicare & Medicaid** | ~$1.53 trillion | 85% |
| **Discretionary Programs** | ~$162 billion | 9% |
| **Other Mandatory** | ~$108 billion | 6% |

### Year-over-Year Growth
- **FY2024 Outlays**: $1.670 trillion
- **FY2025 Outlays**: $1.802 trillion
- **Growth**: +$132 billion (+8%)

### Program Coverage
- **Medicare Beneficiaries**: 65+ million
- **Medicaid Beneficiaries**: 83 million (FY2024)
- **CHIP Coverage**: ~7 million children

---

## PUBLIC RECORD

### 2025 Vaccine Policy Changes

**Advisory Committee Restructuring**
- All members of Advisory Committee on Immunization Practices (ACIP) fired
- Replaced with vaccine-skeptical appointees
- Historical precedent: First complete replacement of standing advisory committee

**Funding and Recommendations**
- $500 million cut from mRNA vaccine development programs
- COVID vaccine recommendations revised: delisted for healthy children and pregnant women
- CDC website modified to include language about vaccine-autism concerns

**Scientific Community Response**
- Multiple medical associations issued statements of concern
- Resignations from career public health officials
- International health organizations monitoring U.S. policy changes

### FDA Approval Process Changes

**Proposed Modifications**
- Additional data requirements for vaccine approvals
- Extended review timelines proposed
- Career staff recommendations overridden in multiple cases

**Novavax Decision**
- Approval process deviated from historical practices
- Internal FDA disagreement documented
- Questions about political influence on scientific review

### Drug Pricing Controversy

**2026 Price Increases**
- 350+ medications with announced price increases
- Pfizer: approximately 80 price increases (some at 15%)
- Inflation Reduction Act price negotiations continuing for Medicare drugs

**User Fee Consideration**
- Pharmaceutical user fee program ($3.3 billion annually) under review
- User fees fund significant portion of FDA review staff
- Elimination would slow drug approval processes

### COVID-19 Response Controversies

**During Pandemic (2020-2023)**
- Opioid crisis exacerbation during pandemic
- PPE and testing supply chain failures
- Vaccine distribution challenges
- Changing guidance on masking, distancing

**Post-Pandemic Review**
- Congressional investigations into origins, response
- Debates over emergency authority use
- Long COVID research and support questions

---

## CONNECTIONS TO OTHER ENTITIES

### Federal Partnerships

| Agency | Coordination Area |
|--------|-------------------|
| **VA** | Fraud prevention, data sharing, joint hiring (December 2019) |
| **Labor (OSHA)** | Workplace health standards, infection control |
| **USDA** | Food safety coordination (FSIS-FDA jurisdiction split) |
| **EPA** | Drinking water safety, environmental health, fluoride standards |
| **Defense** | Biodefense, military health system coordination |

### State Government Relations
- Medicaid administered jointly with states
- State health departments coordinate with CDC
- Public health emergency declarations involve state cooperation

### International Organizations
- WHO collaboration on global health
- International drug approval harmonization
- Disease surveillance data sharing

---

## EDITORIAL ANALYSIS

### The Entitlement Engine

HHS is fundamentally an entitlement processing agency. Medicare and Medicaid consume 85% of its budget—programs that operate largely on autopilot based on eligibility rules and healthcare costs. The policy discretion exercised by HHS leadership affects a small fraction of actual spending.

This creates a peculiar dynamic: the Secretary has enormous symbolic importance but limited fiscal control. Drug pricing, provider reimbursement rates, and coverage decisions matter enormously, but the overall trajectory of healthcare spending responds to demographics and medical costs more than policy choices.

### The Regulatory Paradox

FDA presents the central regulatory tension. Too slow, and patients die waiting for treatments. Too fast, and patients die from inadequately tested drugs. Every approval decision involves this tradeoff, and there's no objectively correct balance point.

The current push to accelerate approvals and reduce requirements represents one answer to this tradeoff—prioritizing access over certainty. Critics argue this risks patient safety for ideological reasons. Supporters argue existing processes are unnecessarily slow. Both positions have merit; the question is how much risk is acceptable.

### Vaccine Policy: Science vs. Politics

The 2025 vaccine policy changes represent the most significant departure from scientific consensus in modern HHS history. The complete replacement of ACIP members and revision of vaccine recommendations breaks decades of precedent where vaccine policy followed advisory committee recommendations based on clinical evidence.

Whether this represents appropriate political accountability over unelected experts or dangerous politicization of public health depends entirely on perspective. What's clear is that vaccine-preventable disease patterns will provide eventual empirical evidence on the policy's effects.

### The RFK Jr. Question

Secretary Kennedy's confirmation placed a longtime vaccine skeptic in charge of the nation's public health apparatus. His stated positions on vaccine-autism connections contradict established scientific consensus. His leadership has already produced substantial policy changes.

This presents the fundamental question of democratic accountability for scientific agencies. The Secretary was nominated by an elected president and confirmed by an elected Senate. The democratic process produced this leadership. Whether democratic processes should override scientific consensus on matters of empirical fact remains contested.

---

## ALTERNATIVE INTERPRETATIONS

### The Reform Perspective
Supporters of current direction argue:
- Public health establishment became insular and resistant to accountability
- Vaccine policy deserves more scrutiny and parental choice
- FDA regulatory burden delays beneficial treatments
- COVID response failures demonstrate need for new approaches

### The Scientific Consensus Perspective
Critics contend:
- Vaccine safety has extensive scientific support
- Politicizing public health endangers population health
- FDA processes protect patients from dangerous treatments
- Workforce reductions will degrade public health capacity

### The Structural Critique
Some observers note:
- HHS is too large to manage effectively
- Entitlement programs should be separated from public health
- FDA dual mandate (promoting and regulating industry) creates conflicts
- Public health requires insulation from political cycles

---

## SOURCES

### Official Sources
- HHS Official Website: https://www.hhs.gov/
- Secretary RFK Jr. Biography: https://www.hhs.gov/about/leadership/robert-kennedy.html
- CMS: https://www.cms.gov/
- CDC: https://www.cdc.gov/
- FDA: https://www.fda.gov/
- NIH: https://www.nih.gov/

### Congressional Sources
- HHS Budget Request (Congress.gov CRS R48060)
- Medicare and Medicaid program analysis

### News Sources
- STAT News healthcare coverage: https://www.statnews.com/
- Medical journal commentary on policy changes

---

## RIGHT OF RESPONSE

*The Department of Health and Human Services has not been contacted for comment on this brief. This section will be updated if official response is received.*

---

**Classification**: OPEN SOURCE COMPILATION
**Version**: 1.0
**Last Updated**: January 2025
**Compiler**: The Continuum Report
